Common Stock and Stock Options | Note 4. Common Stock and Stock Options Stock Based Compensation cost for all stock awards is based on the grant date fair value and recognized over the required service (vesting) period. Non cash stock-based compensation expense was $23,299 and $21,888 for the three months ended March 31, 2022 and 2021, respectively. Unrecognized compensation expense was $5,123 as of March 31, 2022 and will be recognized through 2023. There was no tax benefit recorded for this compensation cost as the expense relates to incentive stock options that do not qualify for a tax deduction until, and only if, a qualifying disposition occurs. The non-employee Board members received compensation of 2,305 and 2,725 aggregate shares of common stock of the Company during the three months ended March 31, 2022 and 2021, respectively. The stock had an aggregate value of $7,491 and $7,494 for the three months ended March 31, 2022 and 2021, respectively, and was recorded as non-cash stock compensation expense in the financial statements. Employees received compensation of 4,500 and 4,804 aggregate shares of common stock of the Company during the three months ended March 31, 2022 and 2021, respectfully. These shares had an aggregate value of $14,625 and $13,211, and was recorded as non-cash stock compensation expense in the financial statements for the three months ended March 31, 2022 and 2021, respectively. In addition, during the three months ended March 31, 2021, a total of 30,181 stock options were exercised by management. The cumulative status of options granted and outstanding at March 31, 2022, and December 31, 2021, as well as options which became exercisable in connection with the Company’s stock option plans is summarized as follows: Employee Stock Options Weighted Average Stock Options Exercise Price Outstanding at January 1, 2021 76,037 $ 1.03 Exercised (34,733) 1.00 Outstanding at December 31, 2021 41,304 $ 1.05 Outstanding at March 31, 2022 41,304 $ 1.05 Options exercisable at December 31, 2021 27,418 $ 0.95 Options exercisable at March 31, 2022 27,418 $ 0.95 Exercise prices for options ranged from $0.84 to $1.25 at March 31, 2022. The weighted average option price for all options outstanding at March 31, 2022, was $0.95 with a weighted average remaining contractual life of 4.6 years. There were no non-employee director stock options outstanding during 2022 and 2021. |